Skip to main content

Advertisement

Log in

Psychiatric Morbidity in Dependent Z-Drugs and Benzodiazepine Users

  • Published:
International Journal of Mental Health and Addiction Aims and scope Submit manuscript

Abstract

Zolpidem/zopiclone (Z-drugs) and benzodiazepines (BDZs) have different profiles of comorbidity, but studies have seldom explored these differences. This study examined psychiatric comorbidity in patients dependent on Z-drugs or BDZs attending substance abuse clinics in Hong Kong. In this retrospective chart review, the medical records of 207 patients (117 on Z-drugs and 90 on BDZs) treated between January 2008 and August 2012 were analysed. Demographic data, patterns of substance misuse and comorbid psychiatric diagnoses were recorded. Patients dependent on Z-drugs were younger (40.5 ± 10.4 vs. 46.8 ± 11.6; p < 0.001), had an earlier age of onset of drug misuse (p = 0.047) and were more likely to currently use cough syrup (29.5 ± 12.1 vs. 33.6 ± 14.5; p = 0.009) than the BDZs dependent patients. Overall, the Z-drugs and BDZs groups had a similar frequency of comorbid psychotic disorders, mood disorders and anxiety disorders. Mood disorders were the most common comorbid psychiatric disorders. The zopiclone group had a significantly higher percentage of psychotic disorders than the zolpidem group (25.5 % vs. 0; p = 0.022). To summarize, patients with Z-drugs or BDZs dependence have similar psychiatric comorbidities, with depressive disorder the most common comorbidity. Zopiclone is more likely to be associated with psychotic disorders than zolpidem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abadie, P., Rioux, P., Scatton, B., Zarifian, E., Barre, L., Patat, A., et al. (1996). Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography. European Journal of Pharmacology, 295(1), 35–44.

    Article  CAS  PubMed  Google Scholar 

  • Ansseau, M., Pitchot, W., Hansenne, M., & Gonzalez Moreno, A. (1992). Psychotic reactions to zolpidem. Lancet, 339(8796), 809.

    Article  CAS  PubMed  Google Scholar 

  • Aranko, K., Henriksson, M., Hublin, C., & Seppalainen, A. M. (1991). Misuse of zopiclone and convulsions during withdrawal. Pharmacopsychiatry, 24(4), 138–140.

    Article  CAS  PubMed  Google Scholar 

  • Brodeur, M. R., & Stirling, A. L. (2001). Delirium associated with zolpidem. Annals of Pharmacotherapy, 35(12), 1562–1564.

    Article  CAS  PubMed  Google Scholar 

  • Busto, U., Romach, M., & Sellers, E. (1996). Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. Journal of Clinical Psychopharmacology, 16(1), 51–57.

    Article  CAS  PubMed  Google Scholar 

  • Goa, K. L., & Heel, R. C. (1986). Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs, 32(1), 48–65.

    Article  CAS  PubMed  Google Scholar 

  • Hajak, G. (1999). A comparative assessment of the risks and benefits of zopiclone: a review of 15 years’ clinical experience. Drug Safety, 21(6), 457–469.

    Article  CAS  PubMed  Google Scholar 

  • Hajak, G., Muller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003). Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction, 98(10), 1371–1378.

    Article  CAS  PubMed  Google Scholar 

  • Holbrook, A. (2004). Treating insomnia. BMJ, 329(7476), 1198–1199.

    Article  PubMed  PubMed Central  Google Scholar 

  • Holm, K. J., & Goa, K. L. (2000). Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs, 59(4), 865–889.

    Article  CAS  PubMed  Google Scholar 

  • Huang, C. L., Chang, C. J., Hung, C. F., & Lin, H. Y. (2003). Zolpidem-induced distortion in visual perception. Annals of Pharmacotherapy, 37(5), 683–686.

    Article  PubMed  Google Scholar 

  • Huedo-Medina, T., Kirsch, I., Middlemass, J., Klonizakis, M., & Siriwardena, A. (2011). Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the food and drug administration. BMJ, 345, e8343.

    Article  Google Scholar 

  • Islam, M., Conigrave, K., Day, C., Nguyen, Y., & Haber, P. (2014). Twenty-years trends in benzodiazepine dispensing in the Australian population. Internal Medicine Journal, 44(1), 57–64.

    Article  CAS  PubMed  Google Scholar 

  • Jones, I. R., & Sullivan, G. (1998). Physical dependence on zopiclone: case reports. BMJ, 316(7125), 117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kahlert, I., & Brune, M. (2001). A case of primary zopiclone dependence. Deutsche Medizinische Wochenschrift, 126(22), 653–654.

    Article  CAS  PubMed  Google Scholar 

  • Kapil, V., Green, J., Le Lait, C., Wood, D., & Dargan, P. (2014). Misuse of benzodiazepines and Z-drugs in the UK. British Journal of Psychiatry, 205(5), 407–408.

    Article  CAS  PubMed  Google Scholar 

  • Kripke, D., Langer, R., & Kline, L. (2012). Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open, 2(1), e000850.

    Article  PubMed  PubMed Central  Google Scholar 

  • Krueger, T. H., Kropp, S., & Huber, T. J. (2005). High-dose zolpidem dependence in a patient with chronic facial pain. Annals of Pharmacotherapy, 39(4), 773–774.

    Article  PubMed  Google Scholar 

  • Lagnaoui, R., Depont, F., Fourrier, A., Abouelfath, A., Bégaud, B., Verdoux, H., et al. (2004). Patterns and correlates of benzodiazepine use in the french general population. European Journal of Clinical Pharmacology, 60(7), 523–529.

    Article  CAS  PubMed  Google Scholar 

  • Lam, M. (2005). Retrospective Study on Characteristics of 104 Zopiclone Abusers in a Substance Abuse Clinic in Hong Kong. Paper presented at the International Conference on Tackling Drug Abuse, Hong Kong.

  • Langer, S. Z., & Arbilla, S. (1988). Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes. Pharmacology, Biochemistry, and Behavior, 29(4), 763–766.

    Article  CAS  PubMed  Google Scholar 

  • Malcolm, R., Brady, K., Johnston, A., & Cunningham, M. (1993). Types of benzodiazepines abused by chemically dependent inpatients. Journal of Psychoactive Drugs, 25(4), 315–319.

    Article  CAS  PubMed  Google Scholar 

  • Markowitz, J. S., & Brewerton, T. D. (1996). Zolpidem-induced psychosis. Annals of Clinical Psychiatry, 8(2), 89–91.

    Article  CAS  PubMed  Google Scholar 

  • Markowitz, J. S., Rames, L. J., Reeves, N., & Thomas, S. G. (1997). Zolpidem and hallucinations. Annals of Emergency Medicine, 29(2), 300–301.

    Article  CAS  PubMed  Google Scholar 

  • Mortaz Hejri, S., Faizi, M., & Babaeian, M. (2013). Zolpidem-induced suicide attempt: a case report. Daru, 21(1), 77.

    Article  PubMed  PubMed Central  Google Scholar 

  • Neckelmann, D., Mykletun, A., & Dahl, A. (2007). Chronic insomnia as a risk factor for developing anxiety and depression. Sleep, 30, 873–880.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pallavicini, J., & Acevedo, X. (1997). Zopiclone dependence. Report of one case. Revista Médica de Chile, 125(3), 336–340.

    CAS  PubMed  Google Scholar 

  • Pitner, J. K., Gardner, M., Neville, M., & Mintzer, J. (1997). Zolpidem-induced psychosis in an older woman. Journal of the American Geriatrics Society, 45(4), 533–534.

    Article  CAS  PubMed  Google Scholar 

  • Sanger, D., & Depoortere, H. (1998). The pharmacology and mechanism of action of zolpidem. CNS Drug Reviews, 4(4), 323–340.

    Article  CAS  Google Scholar 

  • Sethi, P. K., & Khandelwal, D. C. (2005). Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure. Journal of the Association of Physicians of India, 53, 139–140.

    CAS  PubMed  Google Scholar 

  • Sikdar, S., & Ruben, S. M. (1996). Zopiclone abuse among polydrug users. Addiction, 91(2), 285–286.

    Article  CAS  PubMed  Google Scholar 

  • Singh, G. P., & Loona, N. (2013). Zolpidem-induced hallucinations: a brief case report from the Indian subcontinent. Indian Journal of Psychological Medicine, 35(2), 212–213.

    Article  PubMed  PubMed Central  Google Scholar 

  • Siriwardena, A., Qureshi, M., Dyas, J., Middleton, H., & Orner, R. (2008). Magic bullets for insomnia? Patients’ use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. British Journal of General Practice, 58, 417–422.

    Article  PubMed  PubMed Central  Google Scholar 

  • Straand, J., & Rokstad, K. (1997). General practitioners’ prescribing patterns of benzodiazepine hypnotics: are elderly patients at particular risk for overprescribing? A report from the møre & romsdal prescription study. Scandinavian Journal of Primary Health Care, 15(1), 16–21.

    Article  CAS  PubMed  Google Scholar 

  • Stranks, E., & Crowe, S. (2014). The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis. Journal of Clinical and Experimental Neuropsychology, 36(7), 691–700.

    Article  PubMed  Google Scholar 

  • Victorri-Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007). Evidence of zolpidem abuse and dependence: results of the french centre for evaluation and information on pharmacodependence (CEIP) network survey. British Journal of Clinical Pharmacology, 64(2), 198–209.

    Article  PubMed  PubMed Central  Google Scholar 

  • Victorri-Vigneau, C., Feuillet, F., Wainstein, L., Grall-Bronnec, M., Pivette, J., Chaslerie, A., et al. (2013). Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. European Journal of Clinical Pharmacology, 69(11), 1965–1972.

    Article  CAS  PubMed  Google Scholar 

  • Wadworth, A. N., & McTavish, D. (1993). Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs and Aging, 3(5), 441–459.

    Article  CAS  PubMed  Google Scholar 

  • Walsh, J., & Schweitzer, P. (1999). Ten-years trends in the pharmacological treatment of insomnia. Sleep, 22(3), 371–375.

    Article  CAS  PubMed  Google Scholar 

  • Wilson, D. (2011). Zolpidem-induced mania in a patient with schizoaffective disorder. Psychosomatics, 52(5), 493–494.

    Article  PubMed  Google Scholar 

  • Wong, G. Y., Bastiampillai, T., & Dhillon, R. (2010). Potential antipsychotic effects of zolpidem. Australia and New Zezland Journal of Psychiatry, 44(2), 190.

    Article  Google Scholar 

  • Zandstra, S., Furer, J., van de Lisdonk, E., Van’t, H., Bor, J., van Weel, C., et al. (2002). Different study criteria affect the prevalence of benzodiazepine use. Socical Psychiatry and Psychiatric Epidemiology, 37(3), 139–144.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr Shruti Srivastava (Assistant Professor of Psychiatry, University College of Medical Sciences, Dilshad Garden, Delhi, India) for his review and suggestions on the draft of this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wai Kwong Tang.

Ethics declarations

Disclosure of Financial Support

Nothing declared.

Conflict of Interest

The author declares none conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, Y., Tang, W.K., Liang, H.J. et al. Psychiatric Morbidity in Dependent Z-Drugs and Benzodiazepine Users. Int J Ment Health Addiction 15, 555–564 (2017). https://doi.org/10.1007/s11469-016-9679-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11469-016-9679-x

Keywords

Navigation